Ethambutol tuberculosis drug

Ethambutol tuberculosis drug

C011/9967 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 60.2MB

Downloadable file size: 2.4MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Ethambutol tuberculosis (TB) drug. This drug is used in combination with rifampicin, isoniazid and pyrazinamide, as the first-line treatment for TB. Combination therapy is used to prevent the bacteria from becoming resistant to any of the drugs. As the drugs have different mechanisms of action using a combination is also more likely to clear all the bacteria from the body. TB is cased by the bacterium Mycobacterium tuberculosis, which is spread by coughing and sneezing. It infects the lungs creating primary tubercles, nodular lesions of dead tissue and bacteria. The bacteria may enter the blood or lymph system and spread to other organs of the body.

Release details: Model release not required. Property release not available.

Keywords: anti tb, anti tuberculosis, anti-tb, anti-tuberculosis, antibiotic, antibiotics, bottle, combination, combination therapy, combined, drug, ethambutol, first line, first-line, kidney dish, medical, medication, medicine, packaging, pharmaceutics, pharmacological, pharmacology, pill, pills, standard regimen, tablet, tablets, tb, treatment, tuberculosis

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.